Mouse Decay-Accelerating Factor: Selective and Tissue-Specific Induction by Estrogen of the Gene Encoding the Glycosylphosphatidylinositol-Anchored Form

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4166-4172

  Song, Wen Chao ^a   Deng, Chengjun ^a   Raszmann, Kimberly ^b   Moore, Rick ^b   Newbold, Retha ^b   McLachlan, John A ^b,c   Negishi, Masahiko ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DECAY ACCELERATING FACTOR; DIETHYLSTILBESTROL; GLYCOSYLPHOSPHATIDYLINOSITOL; MESSENGER RNA; TAMOXIFEN;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; MOLECULAR GENETICS; MOUSE; NEWBORN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; UTERUS;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD55; BASE SEQUENCE; DIETHYLSTILBESTROL; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION; GENES; GLYCOSYLPHOSPHATIDYLINOSITOLS; LIVER; MICE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; OVARIECTOMY; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TAMOXIFEN; UTERUS;

EID: 0030293632     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Holers, V. M., T. Kinoshita, and H. Molina. 1992. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. Immunol. Today 13:231.
2. Morgan, B. P., and S. Meri. 1994. Membrane proteins that protect against complement lysis. Springer Semin. Immunol. 15:369.
3. Davitz, M. A., M. G. Low, and V. Nussenzweig. 1986. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC): selective modification of a complement regulatory protein. J. Exp. Med. 163:1150.
4. Holguin, M. H., and C. J. Parker. 1992. Membrane inhibitor of reactive lysis. Curr. Top. Microbiol. Immunol. 178:61.
5. Liszewski, M. K., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431.
6. Nicholson-Weller, A., J. Burge, D. T. Fearon, P. F. Weller, and K. F. Austen. 1982. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 129:184.
7. Lublin, D., and J. P. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35.
8. Kingsmore, S. F., D. P. Vik, C. B. Kurtz, P. Leroy, B. F. Tack, J. H. Weis, and M. F. Seldin. 1989. Genetic organization of complement receptor-related genes in the mouse. J. Exp. Med. 169:1479.
9. Molina, H., W. Wong, T. Kinoshita, C. Brenner, S. Foley, and V. M. Holers. 1992. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1. J. Exp. Med. 175:121.
10. Aegerter-Shaw, M., J. C. Cole, L. B. Klickstein, W. W. Wong, D. T. Fearon, P. A. Lalley, and J. H. Weis. 1987. Expansion of the complement receptor gene family: identification in the mouse of two new genes related to the CR1 and CR2 gene family. J. Immunol. 138:3488.
11. Paul, M. S., M. Aegerter, K. Cepek, M. D. Miller, and J. H. Weis. 1990. The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes. J. Immunol. 144:1988.
12. Paul, M. S., M. Aegerter, S. E. O'Brien, C. B. Kurtz, and J. H. Weis. 1989. The murine complement receptor gene family: analysis of mCRY gene products and their homology to human CR1. J. Immunol. 142:582.
13. Li, B., C. Sallee, M. Dehoff, S. Foley, H. Molina, and V. M. Holers. 1993. Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151:4295.
14. Kim, Y.-U., T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L. M. Wagner, and V. M. Holers. 1995. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181:151.
15. Newbold, R. R., B. C. Bullock, and J. A. McLachlan. 1990. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res. 50:7677.
16. Medorf, M. E., D. M. Lublin, V. M. Holers, D. J. Ayers, R. R. Getty, J. F. Leykam, J. P. Atkinson, and M. L. Tykocinski. 1987. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA 84:2007.
17. Caras, I. W., M. A. Davitz, L. Rhee, G. Weddell, D. W. Martin, Jr., and V. Nussenzweig. 1987. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545.
18. Spicer, A. P., M. F. Seldin, and S. J. Gendler. 1995. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes: duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J. Immunol. 155:3079.
19. Liang, P., and A. B. Pardee. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967.
20. Frohman, M. A. 1990. RACE: rapid amplification of cDNA ends. In PCR Protocols, a Guide to Methods and Applications. M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White, eds. Academic Press, New York, pp. 46-53.
21. Caras, I. W., G. N. Weddell, M. A. Davitz, V. Nussenzweig, and D. W. Martin, Jr. 1987. Signal for attachment of a phospholipid membrane anchor in decay accelerating factor. Science 238:1280.
22. Nelson, K. G., Y. Sakai, B. Eitzman, T. Steed, and J. A. McLachLan. 1994. Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ. 5:595.
23. Kameyoshi, Y., M. Matsushita, and H. Okada. 1989. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase. Immunology 68:439.
24. Gray, K., B. Eitzman, K. Raszmann, T. Steed, A. Geboff, J. A. McLachlan, and M. Bidwell. 1995. Coordinate regulation by diethylstilbestrol of the platelet-derived growth factor-A (PDGF-A) and -B chains and the PDGF receptor alpha- and beta-subunits in the mouse uterus and vagina: potential mediators of estrogen action. Endocrinology 136:2325.
25. Hasty, L. A., J. D. Lambris, B. A. Lessey, K. Pruksananonda, and C. R. Lyttle. 1994. Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am. J. Obstet. Gynecol. 170:168.
26. Kaul, A., B. J. Nowicki, M. G. Martens, P. Goluszko, A. Hart, M. Nagamani, D. Kumar, T. Q. Pham, and S. Nowicki. 1994. Decay-accelerating factor is expressed in the human endometrium and may serve as the attachment ligand for Dr pili of Escherichia coli. Am. J. Reprod. Immunol. 32:194.
27. Sundstrom, S. A., B. S. Komm, H. Ponce-de-Leon, Y. Zheng, C. Teuscher, and C. R. Lyttle. 1989. Estrogen regulation of tissue-specific expression of complement C3. J. Biol. Chem. 264:16941.
28. Fornander, T., L. E. Rutqvist, B. Cedermark, U. Glas, A. Mattsson, C. Silfversward, L. Skoog, A. Somell, T. Theve, N. Wilking, et al. 1989. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancer. Lancet 1:117.
29. Clark, J. H., and J. H. Gunthrie. 1981. Agonistic and antagonistic effects of clomiphene citrate and its isomers. Biol. Reprod. 25:667.
30. Sundstrom, S. A., B. S. Komm, Q. Xu, V. Boundy, and C. R. Lyttle. 1990. The stimulation of uterine complement component C3 gene expression by antiestrogens. Endocrinology 126:1449.
31. Cervoni, F., T. J. Oglesby, P. Fenichel, G. Dohr, B. Rossi, J. P. Atkinson, and B. L. Hsi. 1993. Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa. J. Immunol. 151:939.
32. Simpson, K. L., and C. H. Holmes. 1994. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis. Immunology 81:452.
33. Cheung, N.-K. V., E. I. Walter, W. H. Smith-Mensah, W. D. Ratnoff, M. L. Tykocinski, and M. E. Medof. 1988. Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. J. Clin. Invest. 81: 1122.
34. Koretz, K., S. Bruderlein, C. Henne, and P. Moller. 1992. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br. J. Cancer 66:810.
35. Stefanova, I., V. Horejsi, I. J. Ansotegui, W. Knapp, and H. Stockinger. 1991. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016.
36. fyn. J. Immunol. 149:3535.
37. Davis, L. S., S. S. Patel, J. P. Atkinson, and P. E. Lipsky. 1988. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J. Immunol. 141:2248.